Mayne Pharma Group (AU:MYX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mayne Pharma Group successfully completed an on-market share buy-back, repurchasing over 3.8 million shares for approximately AU$17.16 million between May 2023 and May 2024. The company announced the potential for further share buy-backs later in 2024 but did not execute any additional purchases in the subsequent period. This move is likely part of Mayne Pharma’s strategy to enhance shareholder value and optimize capital management.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.